EdgarLookup

Karyopharm Therapeutics Inc. — SC 13G/A Filings

63 SC 13G/A filings on record

This page lists all SC 13G/A filings submitted to the SEC by Karyopharm Therapeutics Inc. (KPTI), sorted by most recent first. Each row links to the full filing on EdgarLookup. Karyopharm Therapeutics Inc. has filed 63 SC 13G/A documents with the SEC since 2014. To view all SEC filings by Karyopharm Therapeutics Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 10-Q/A 144 3 4 4/A 424B3 424B4 424B5 5 8-A12B 8-K ARS CERTNAS CORRESP CT ORDER D DEF 14A DEFA14A DRS DRSLTR EFFECT POS AM POSASR PRE 14A RW S-1 S-1/A S-1MEF S-3 S-3/A S-3ASR S-8 SC 13D SC 13D/A SC 13G SC 13G/A SC TO-C SC TO-I SC TO-I/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
SC 13G/A 0000919574-24-006742 Nov 14, 2024
SC 13G/A 0000932471-24-001032 Nov 12, 2024
SC 13G/A 0000932471-24-000431 Nov 4, 2024
SC 13G/A 0001086364-24-008142 Jul 8, 2024
SC 13G/A 0001306923-24-000004 Feb 14, 2024
SC 13G/A 0000919574-24-001291 Feb 14, 2024
SC 13G/A SC 13G/A 0001104659-24-013556 Feb 12, 2024
SC 13G/A 0001086364-24-003344 Jan 25, 2024
SC 13G/A 0001306923-23-000006 Feb 14, 2023
SC 13G/A 0001493152-23-004859 Feb 14, 2023
SC 13G/A AMENDMENT NO. 8 TO SCHEDULE 13G 0001213900-23-011440 Feb 14, 2023
SC 13G/A 0000919574-23-001620 Feb 14, 2023
SC 13G/A 0001306550-23-004203 Jan 26, 2023
SC 13G/A 0001306923-22-000012 Feb 14, 2022
SC 13G/A SC 13G/A 0001193125-22-036941 Feb 11, 2022
SC 13G/A AMENDMENT NO. 7 TO SCHEDULE 13G 0001213900-22-006930 Feb 11, 2022
SC 13G/A 0000834237-22-001166 Jan 26, 2022
SC 13G/A CONSONANCE CAPITAL MANAGEMENT LP 0001085146-21-001037 Feb 17, 2021
SC 13G/A 0001306923-21-000018 Feb 16, 2021
SC 13G/A SC 13G/A 0001193125-21-044994 Feb 16, 2021
SC 13G/A AMENDMENT NO. 6 TO SCHEDULE 13G 0001213900-21-009573 Feb 16, 2021
SC 13G/A CONSONANCE CAPITAL MANAGEMENT LP 0001085146-21-000926 Feb 16, 2021
SC 13G/A KARYOPHARM THERAPEUTICS INC. 0000902664-21-001247 Feb 12, 2021
SC 13G/A KARYOPHARM THERAPEUTICS INC. 0000902664-21-001151 Feb 11, 2021
SC 13G/A 0000834237-21-002036 Jan 27, 2021
SC 13G/A SCHEDULE 13G/A, AMENDMENT #1 0000899140-20-000182 Feb 14, 2020
SC 13G/A SC 13G/A 0001104659-20-021717 Feb 14, 2020
SC 13G/A AMENDMENT NO.5 TO SCHEDULE 13G 0001213900-20-003917 Feb 14, 2020
SC 13G/A 0001306923-20-000011 Feb 14, 2020
SC 13G/A CONSONANCE CAPITAL MANAGEMENT LP 0001085146-20-000771 Feb 14, 2020
SC 13G/A SC 13G/A 0001193125-20-035536 Feb 13, 2020
SC 13G/A KARYOPHARM THERAPEUTICS INC. 0000902664-20-000963 Feb 12, 2020
SC 13G/A 0001319244-20-000038 Feb 6, 2020
SC 13G/A 0000834237-20-005881 Feb 5, 2020
SC 13G/A SEC SCHEDULE 13G 0000902219-19-000465 Nov 8, 2019
SC 13G/A SC 13G/A 0001306923-19-000005 Feb 14, 2019
SC 13G/A SC 13G/A 0001144204-19-008172 Feb 14, 2019
SC 13G/A SCHEDULE 13G/A, #2 0000899140-19-000223 Feb 14, 2019
SC 13G/A AMENDMENT NO. 4 TO SCHEDULE 13G 0001213900-19-002322 Feb 13, 2019
SC 13G/A SEC SCHEDULE 13G 0000902219-19-000193 Feb 12, 2019
SC 13G/A SC 13G/A 0001193125-19-033944 Feb 11, 2019
SC 13G/A 0000215457-19-004847 Feb 6, 2019
SC 13G/A 0000315066-18-001920 May 10, 2018
SC 13G/A 0001306923-18-000007 Feb 14, 2018
SC 13G/A AMENDMENT NO. 1 0000899140-18-000238 Feb 14, 2018
SC 13G/A SCHEDULE 13G 0001213900-18-001766 Feb 14, 2018
SC 13G/A 0000315066-18-001393 Feb 13, 2018
SC 13G/A SC 13G AMENDMENT NO. 4 0001193125-18-041424 Feb 13, 2018
SC 13G/A SEC SCHEDULE 13G 0000902219-18-000141 Feb 8, 2018
SC 13G/A 0000315066-17-001793 Feb 14, 2017